MSB 4.52% 95.0¢ mesoblast limited

Cell Therapy News/Articles, page-12671

  1. 5,144 Posts.
    lightbulb Created with Sketch. 573
    good find, the last bit about acceptable as a treatment due to barriers in approval and cost, and mechanism by which it work an issue...
    does MSB hold the patents for those other trialing too.

    also great news, 4 treated, 4 in remission, followup over 2 years...a long time, fast track must be had,
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.